SOTIO partners with Biocytogen to expand ADC pipeline
Czech Sotio Biotech has inked an R&D and licence option agreement with Chinese antibody maker Biocytogen.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1118 entries already.
Entries by Thomas Gabrielczyk
Draupnir Bio ApS raises further equity
/in News/by Thomas GabrielczykTargeted protein degradation Draupnir Bio Aps has raised further €12m in an equitiy investment to advance its preclinical pipeline.
CordenPharma invests €900m in peptide patform expansion
/in News/by Thomas GabrielczykCordenPharma is making a record investment of about €900m over the next three years in expanding its peptide platform, both at its Colorado, US site and in Europe.
Catalym raises US$150m
/in News/by Thomas GabrielczykGerman cancer specialist Catalym GmbH has raised US$150m to finance proof-of-concept studies.
Sensorion achieves milestones in Phase II trial
/in News/by Thomas GabrielczykFrench Sensorion SA has reported new efficacy endpoints data from SENS-401 in a Phase II study for the preservation of residual hearing loss.
Rentschler doubles cGMP capacity
/in News/by Thomas GabrielczykIn the largest expansion in the company’s 150-year history, the Laupheim-headquartered CDMO Rentschler Biopharma SE has launched a new production line at its site in Milford, USA.
SciRhom GmbH closes €63m Series A financing
/in News/by Thomas GabrielczykGerman iRhom2-targeted antibody specialist SciRhom GmbH has closed an oversubscribed €63m Series A financing that will be used to provide clinical proof of concept in autoimmune disorders.
Ligand Pharma to acquire Apeiron Biologics
/in News/by Thomas GabrielczykAustrian Apeiron Biologics goes to Ligand Pharmaceuticals for US$100m.
EMA-Gate: PharmaMar wins suit against EMA
/in News/by Thomas GabrielczykThe European Commission has fully upheld the complaint by PharmaMar SA due to conflicts of interest of leading EMA experts in the (non-)authorisation of Aplidin.
EuroscreenFast and GW Vitek announce distribution partnership in Korea
/in News/by Thomas GabrielczykBelgium-headquarted GCPR-screening specialist EuroscreenFast and Asian distributor GW Vitek have inked a strategic collaboration.